[Clinical experience with a new antihistaminic].
D000208:Acute Disease; D002908:Chronic Disease; D003873:Dermatitis, Exfoliative / Q000188:drug therapy; D004342:Drug Hypersensitivity; D004485:Eczema / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D009450:Neurodermatitis / Q000188:drug therapy; D010406:Penicillins / Q000009:adverse effects; D011239:Prednisolone / Q000627:therapeutic use; D011536:Prurigo / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D010406:Penicillins; D011239:Prednisolone
Klinische Erfahrungen mit einem neuen Antihistaminikum.